WM Analyst's  Instablog

WM Analyst
Send Message
WM Analyst is a team of analysts dedicated to discovering novel methods of research and introducing insights regarding securities that may be glanced over by the individual investor. Based in New Jersey, WM Analyst is focused on finding subtle missteps in the market that when corrected will... More
  • KaloBios Pharmaceuticals IPO Revision 0 comments
    Jan 31, 2013 11:44 AM | about stocks: LPDX, STML, KBIO

    Yesterday, KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO) increased the amount it hopes to raise in its initial public offering, according to the amended S-1 filling with the Securities and Exchange Commission.

    The company said it plans to sell 9.48 million shares for between $8 and $9 a share, valuing the deal at as much as $85.39 million. The company previously filed with the SEC that it planned to sell 3.85 million shares at between $12 and $14 a share, for a maximum deal size of $53.9 million.

    Primary Cause to Revision

    KaloBios boosted the size of its offering after two other health-care IPOs over the past week have posted double-digit percentage gains on Day One.

    On Tuesday, biopharmaceutical company Stemline Therapeutics Inc. (NASDAQ:STML) raised its deal size and still managed an 18% first-day rise. Further, last week, LipoScience Inc. (NASDAQ:LPDX) gained 16% on its first day trading.

    Management at KaloBios realized the immediate return from their IPO will likely be higher based on the past two similar companies IPO around this time.

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

    Stocks: LPDX, STML, KBIO
Back To WM Analyst's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.